A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis

J Thromb Haemost. 2005 Nov;3(11):2487-96. doi: 10.1111/j.1538-7836.2005.01624.x.

Abstract

Background: Factor (F)XIII B-subunit, which plays a carrier role for zymogen FXIIIA, is highly polymorphic, but the molecular basis for these polymorphisms and their relationship to disease remains unknown.

Objectives: To screen the FXIIIB gene coding region for common variation and analyze possible functional effects.

Methods and results: We examined the FXIIIB gene by PCR-SSCP and identified three common single nucleotide polymorphisms: A8259G, C29470T and A30899G. A8259G results in substitution of His95Arg in the second Sushi domain. An FXIII tetramer ELISA was developed to analyze B-subunit dissociation from A-subunit (leading to access to the catalytic site of FXIII). Increased subunit dissociation, 0.51 vs. 0.45 (fraction of total tetramer), was found in plasma from subjects possessing the Arg-allele. However, when the variants were purified to homogeneity and binding was analyzed by steady-state kinetics, no difference was observed. The relationship between His95Arg and venous thrombosis was investigated in 214 patients and 291 controls from Leeds. His/Arg + Arg/Arg genotypes were more frequent in patients than controls (22.4% vs. 15.1%). His95Arg was also investigated in the Leiden Thrombophilia Study, in which a similar difference was observed for 471 patients vs. 472 controls (18.5% vs. 14.0%), for a pooled odds ratio (OR) of 1.5 (CI95 1.1-2.0).

Conclusions: We have identified three FXIIIB polymorphisms, one of which codes for substitution of His95Arg. The Arg95 variant associates with a moderately increased risk for venous thrombosis, and with increased dissociation of the FXIII subunits in plasma, although in vitro steady-state binding between purified subunits was not affected.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Factor XIII / chemistry
  • Factor XIII / genetics*
  • Factor XIII / isolation & purification
  • Female
  • Gene Frequency
  • Genetic Testing
  • Genotype
  • Heterozygote
  • Homozygote
  • Humans
  • Kinetics
  • Male
  • Mutation
  • Phenotype
  • Polymorphism, Single Nucleotide*
  • Protein Structure, Tertiary / genetics
  • Risk Factors
  • Thromboembolism / etiology
  • Thromboembolism / genetics*
  • Venous Thrombosis / etiology
  • Venous Thrombosis / genetics*

Substances

  • factor XIII subunit A
  • Factor XIII
  • factor XIIIb